global
pandem
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
declar
world
health
organ
march
current
clinic
diagnosi
confirm
detect
rna
molecular
diagnost
laboratori
use
time
revers
transcriptionpolymeras
chain
reaction
rrtpcr
analyz
two
region
n
gene
use
detect
rna
simplex
step
rrtpcr
use
previous
describ
primerprob
set
nsarbeco
three
gene
design
sarbecovirusspecif
e
gene
esarbeco
target
sarscov
use
synthet
rna
control
n
gene
ctrln
previous
describ
lod
analyz
use
serial
dilut
synthet
control
rna
sampl
copiesreact
c
q
valu
detect
rate
shown
tabl
compar
three
primerprob
set
niidn
nsarbeco
esarbeco
esarbeco
compar
c
q
valu
simplex
multiplex
rrtpcr
use
six
posit
sampl
figur
observ
good
correl
target
howev
c
q
valu
nsarbeco
show
averag
delay
cycl
minimum
maximum
similar
result
c
q
valu
obtain
use
simplex
niidn
multiplex
niidn
multiplex
esarbeco
result
indic
sensit
niidn
decreas
multiplex
esarbeco
niidn
equal
sensit
also
test
anoth
nucleic
acid
extract
kit
high
pure
viral
rna
kit
roch
although
c
q
valu
slightli
higher
obtain
use
maxwel
rsc
viral
total
nucleic
acid
test
result
obtain
use
novel
multiplex
rrtpcr
shown
figur
twentyfour
clinic
specimen
analyz
four
posit
twenti
neg
result
develop
multiplex
rrtpcr
methodolog
molecular
diagnosi
sensit
rtpcr
affect
variou
factor
nucleic
acid
extract
method
onestep
rtpcr
reagent
primerprob
set
optim
experi
requir
prior
use
methodolog
clinic
set
current
result
indic
niidn
set
slightli
sensit
esarbeco
niidn
esarbeco
good
combin
detect
two
region
genom
high
sensit
human
gene
use
ic
check
qualiti
specimen
nucleic
acid
extract
step
rtpcr
amplif
therefor
demonstr
highli
sensit
multiplex
rrtpcr
methodolog
detect
human
gene
recommend
ic
gene
molecular
diagnosi
monitor
minim
residu
diseas
detect
mani
molecular
diagnost
laboratori
use
primerprob
set
use
actb
gapdh
gene
also
frequent
use
ic
abundantli
express
gene
multiplex
pcr
amplif
highli
abund
target
may
prevent
amplif
less
abund
target
possibl
lower
sensit
target
detect
background
esarbeco
slightli
increas
later
cycl
judg
signal
neg
result
reproduc
poor
neg
upon
retest
assay
niidn
show
posit
result
although
equal
sensit
sinc
result
may
lead
falseposit
result
care
must
taken
judg
weak
posit
signal
pandem
result
shortag
reagent
relat
molecular
diagnosi
propos
multiplex
rrtpcr
methodolog
enabl
highli
sensit
detect
rna
reduc
reagent
use
cost
time
requir
clinic
